CDTX logo

Cidara Therapeutics (CDTX) Current Liabilities

Annual Current Liabilities

$67.42 M
+$26.02 M+62.85%

31 December 2023

CDTX Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$44.34 M
+$4.70 M+11.85%

30 September 2024

CDTX Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CDTX Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+62.9%+24.5%
3 y3 years+74.8%+32.4%
5 y5 years+238.9%+40.4%

CDTX Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+98.2%-34.2%+41.1%
5 y5 yearsat high+238.9%-34.2%+49.6%
alltimeall timeat high>+9999.0%-34.2%+1345.2%

Cidara Therapeutics Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$44.34 M(+11.8%)
June 2024
-
$39.64 M(-39.4%)
Mar 2024
-
$65.42 M(-3.0%)
Dec 2023
$67.42 M(+62.8%)
$67.42 M(+89.3%)
Sept 2023
-
$35.62 M(+13.4%)
June 2023
-
$31.42 M(-11.9%)
Mar 2023
-
$35.66 M(-13.9%)
Dec 2022
$41.40 M(+21.7%)
$41.40 M(+25.3%)
Sept 2022
-
$33.05 M(+5.1%)
June 2022
-
$31.45 M(-2.0%)
Mar 2022
-
$32.10 M(-5.6%)
Dec 2021
$34.02 M(-11.8%)
$34.02 M(+1.6%)
Sept 2021
-
$33.49 M(-1.2%)
June 2021
-
$33.89 M(-15.2%)
Mar 2021
-
$39.97 M(+3.6%)
Dec 2020
$38.56 M(+27.7%)
$38.56 M(+13.9%)
Sept 2020
-
$33.87 M(+7.3%)
June 2020
-
$31.57 M(+6.5%)
Mar 2020
-
$29.63 M(-1.9%)
Dec 2019
$30.20 M
$30.20 M(-4.4%)
DateAnnualQuarterly
Sept 2019
-
$31.58 M(+69.7%)
June 2019
-
$18.61 M(-1.5%)
Mar 2019
-
$18.90 M(-5.0%)
Dec 2018
$19.89 M(+64.6%)
$19.89 M(+46.7%)
Sept 2018
-
$13.56 M(-9.1%)
June 2018
-
$14.92 M(+29.5%)
Mar 2018
-
$11.52 M(-4.7%)
Dec 2017
$12.09 M(+35.6%)
$12.09 M(+40.2%)
Sept 2017
-
$8.62 M(-19.1%)
June 2017
-
$10.66 M(+54.8%)
Mar 2017
-
$6.89 M(-22.7%)
Dec 2016
$8.91 M(+49.1%)
$8.91 M(+8.2%)
Sept 2016
-
$8.23 M(+60.6%)
June 2016
-
$5.13 M(+26.4%)
Mar 2016
-
$4.06 M(-32.1%)
Dec 2015
$5.97 M(+85.9%)
$5.97 M(+39.7%)
Sept 2015
-
$4.28 M(+39.3%)
June 2015
-
$3.07 M(-19.5%)
Mar 2015
-
$3.81 M(+18.5%)
Dec 2014
$3.21 M(+2669.8%)
$3.21 M
Dec 2013
$116.00 K
-

FAQ

  • What is Cidara Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Cidara Therapeutics?
  • What is Cidara Therapeutics annual current liabilities year-on-year change?
  • What is Cidara Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Cidara Therapeutics?
  • What is Cidara Therapeutics quarterly current liabilities year-on-year change?

What is Cidara Therapeutics annual total current liabilities?

The current annual current liabilities of CDTX is $67.42 M

What is the all time high annual current liabilities for Cidara Therapeutics?

Cidara Therapeutics all-time high annual total current liabilities is $67.42 M

What is Cidara Therapeutics annual current liabilities year-on-year change?

Over the past year, CDTX annual total current liabilities has changed by +$26.02 M (+62.85%)

What is Cidara Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of CDTX is $44.34 M

What is the all time high quarterly current liabilities for Cidara Therapeutics?

Cidara Therapeutics all-time high quarterly total current liabilities is $67.42 M

What is Cidara Therapeutics quarterly current liabilities year-on-year change?

Over the past year, CDTX quarterly total current liabilities has changed by +$8.72 M (+24.48%)